BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8764340)

  • 1. Intrathecal nicotinic agonist-elicited release of excitatory amino acids as measured by in vivo spinal microdialysis in rats.
    Khan IM; Marsala M; Printz MP; Taylor P; Yaksh TL
    J Pharmacol Exp Ther; 1996 Jul; 278(1):97-106. PubMed ID: 8764340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nociceptive and antinociceptive responses to intrathecally administered nicotinic agonists.
    Khan IM; Buerkle H; Taylor P; Yaksh TL
    Neuropharmacology; 1998 Dec; 37(12):1515-25. PubMed ID: 9886674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular and behavioral responses to nicotinic agents administered intrathecally.
    Khan IM; Taylor P; Yaksh TL
    J Pharmacol Exp Ther; 1994 Jul; 270(1):150-8. PubMed ID: 8035311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epibatidine binding sites and activity in the spinal cord.
    Khan IM; Yaksh TL; Taylor P
    Brain Res; 1997 Apr; 753(2):269-82. PubMed ID: 9125412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A-85380 and epibatidine each interact with disparate spinal nicotinic receptor subtypes to achieve analgesia and nociception.
    Khan IM; Stanislaus S; Zhang L; Taylor P; Yaksh TL
    J Pharmacol Exp Ther; 2001 Apr; 297(1):230-9. PubMed ID: 11259549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmented responses to intrathecal nicotinic agonists in spontaneous hypertension.
    Khan IM; Printz MP; Yaksh TL; Taylor P
    Hypertension; 1994 Nov; 24(5):611-9. PubMed ID: 7960022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulatory pathways and sites of action of intrathecally administered nicotinic agents.
    Khan IM; Taylor P; Yaksh TL
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1550-7. PubMed ID: 7996469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathy-specific analgesic action of intrathecal nicotinic agonists and its spinal GABA-mediated mechanism.
    Rashid MH; Ueda H
    Brain Res; 2002 Oct; 953(1-2):53-62. PubMed ID: 12384238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different presynaptic nicotinic receptor subtypes modulate in vivo and in vitro the release of glycine in the rat hippocampus.
    Zappettini S; Mura E; Grilli M; Preda S; Salamone A; Olivero G; Govoni S; Marchi M
    Neurochem Int; 2011 Oct; 59(5):729-38. PubMed ID: 21762741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus and hypothermic effects of some derivatives of the nAChR agonist epibatidine in mice.
    Rodriguez JS; Cunningham CS; Moura FB; Ondachi P; Carroll FI; McMahon LR
    Psychopharmacology (Berl); 2014 Dec; 231(23):4455-66. PubMed ID: 24800895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced antinociception by nicotinic receptor agonist epibatidine and adrenal medullary transplants in the spinal subarachnoid space.
    Caban AJ; Hama AT; Lee JW; Sagen J
    Neuropharmacology; 2004 Jul; 47(1):106-16. PubMed ID: 15165838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current.
    Alkondon M; Albuquerque EX
    J Pharmacol Exp Ther; 1995 Aug; 274(2):771-82. PubMed ID: 7543571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (+/-) Epibatidine increases acetylcholine release partly through an action on muscarinic receptors.
    Kommalage M; Höglund AU
    Basic Clin Pharmacol Toxicol; 2004 May; 94(5):238-44. PubMed ID: 15125694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
    Khan IM; Yaksh TL; Taylor P
    J Pharmacol Exp Ther; 1994 Jul; 270(1):159-66. PubMed ID: 8035312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of microdialyzed oxotremorine, carbachol, epibatidine, and scopolamine on intraspinal release of acetylcholine in the rat.
    Höglund AU; Hamilton C; Lindblom L
    J Pharmacol Exp Ther; 2000 Oct; 295(1):100-4. PubMed ID: 10991966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of rat spinal substance P receptor bearing neurons dissociates cardiovascular and nocifensive responses to nicotinic agonists.
    Khan IM; Wart CV; Singletary EA; Stanislaus S; Deerinck T; Yaksh TL; Printz MP
    Neuropharmacology; 2008 Feb; 54(2):269-79. PubMed ID: 18037142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine-stimulated release of [3H]norepinephrine from fetal rat locus coeruleus cells in culture.
    Gallardo KA; Leslie FM
    J Neurochem; 1998 Feb; 70(2):663-70. PubMed ID: 9453560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for nicotinic receptors potentially modulating nociceptive transmission at the level of the primary sensory neuron: studies with F11 cells.
    Puttfarcken PS; Manelli AM; Arneric SP; Donnelly-Roberts DL
    J Neurochem; 1997 Sep; 69(3):930-8. PubMed ID: 9282914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal nicotinic receptor expression in spontaneously hypertensive rats.
    Khan IM; Youngblood KL; Printz MP; Yaksh TL; Taylor P
    Hypertension; 1996 Dec; 28(6):1093-9. PubMed ID: 8952602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses.
    Mellon RD; Bayer BM
    J Pharmacol Exp Ther; 1999 Feb; 288(2):635-42. PubMed ID: 9918569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.